Cosmax BTI, Inc.

Research Cosmax BTI, Inc. (044820.KS) on Bullrun: market cap KRW 221.19B, dividend yield 3.6%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is KRW 221.19B; dividend yield is 3.6%.

Peer valuation comparison

Latest dividend yield is 3.56% versus a Consumer Defensive sector median of 2.98% (19.5% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18KRW 221.19Bn/a3.4%780

Dividend history

Latest trailing dividend snapshot: annual dividend/share 780 KRW, yield 3.6%.

About Cosmax BTI, Inc.

Cosmax BTI, Inc. engages in the research, development, production, and sale of cosmetics, health functional foods, pharmaceuticals, and special containers in South Korea. The company offers cosmetics products, including skincare, mask, cleansing, hair, bath and body, sun care, makeup, cushion, eye and lip makeup, nail, and fragrance products; baby and child cosmetic products; Korean herbal cosmetics; and cosmeceuticals. It also provides health supplement products in form of gels, capsules, and powders;

Related stock research

Other Consumer Defensive stocks

Frequently asked questions

What is Cosmax BTI, Inc.'s market cap?

Cosmax BTI, Inc.'s market capitalization is KRW 221.19B.

Does Cosmax BTI, Inc. pay a dividend?

Cosmax BTI, Inc. has a dividend yield of 3.6%.

What does Cosmax BTI, Inc. do?

Cosmax BTI, Inc. engages in the research, development, production, and sale of cosmetics, health functional foods, pharmaceuticals, and special containers in South Korea. The company offers cosmetics products, including skincare, mask, cleansing, hair, bath and body, sun care, makeup, cushion, eye and lip makeup, nail, and fragrance products; baby and child cosmetic products; Korean herbal cosmetics; and cosmeceuticals. It also provides health supplement products in form of gels, capsules, and powders; and medical devices. In addition, the company exports its products. Cosmax BTI, Inc.